Deivanayagabarathy Vinayagam

Deivanayagabarathy Vinayagam

Auto-generated profile, based on publicly available information

Deivanayagabarathy Vinayagam

Department of Structural Biochemistry, Max Planck Institute of Molecular Physiology, Dortmund, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2020 in eLife
Verified
Journal Article
Open access
DVDeivanayagabarathy Vinayagam
Deivanayagabarathy Vinayagam
DQDennis Quentin
Dennis Quentin
JYJing Yu-Strzelczyk
Jing Yu-Strzelczyk
OSOleg Sitsel
Oleg Sitsel
FMFelipe Merino
Felipe Merino
SRStefan Raunser
Stefan Raunser
Canonical transient receptor potential channels (TRPC) are involved in receptor-operated and/or store-operated Ca2+ signaling. Inhibition of TRPCs by small molecules was shown to be promising in treating renal diseases. In cells, the channels are regulated by calmodulin (CaM). Molecular details of both CaM and drug binding have remained elusive so far. Here, we report structures of TRPC4 in complex with three pyridazinone-based inhibitors and CaM. The structures reveal that all the inhibitors bind to the same cavity of the voltage-sensing-like domain and allow us to describe how structural changes from the ligand-binding site can be transmitted to the central ion-conducting pore of TRPC4. CaM binds to the rib helix of TRPC4, which results in the ordering of a previously disordered region, fixing the channel in its closed conformation. This represents a novel CaM-induced regulatory mechanism of canonical TRP channels.

16 January 2026 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
MMMarkus Müller
Markus Müller
KNKonstantin Niemeyer
Konstantin Niemeyer
Navin Kumar OjhaNavin Kumar Ojha
Navin Kumar Ojha
SPSebastian A. Porav
Sebastian A. Porav
DVDeivanayagabarathy Vinayagam
Deivanayagabarathy Vinayagam
OTOliver Thorn-Seshold
Oliver Thorn-Seshold
Precisely probing the endogenous roles of target proteins is crucial for biological research. Photochemical tools can be photoactuated with high spatiotemporal resolution but often they are unreliable in vivo because spatiotemporal variations of reagent concentration result in inhomogeneous bioactivity. We now describe ideal efficacy photoswitching, a paradigm that internally compensates for reagent concentration by self-competitive binding, allowing purely wavelength-dependent chromocontrol over bioactivity that is consistent from cell culture to deep tissues. We demonstrate this with photoswitches for endogenous transient receptor potential (TRP) C4 and C5 ion channels, reproducibly delivering strong agonism under 360-nm illumination, weak agonism under 385-nm illumination and strong antagonism under 440-nm illumination. These ligands unlock a range of high-precision investigations in TRP biology, from neuronal activity to exocytosis, reproductive signaling and smooth muscle contractility. The ideal efficacy photoswitching paradigm should also unlock high-performance chromocontrol over a wide range of sensory or signaling channels and receptors even in vivo.

13 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MMMarkus Müller
Markus Müller
KNKonstantin Niemeyer
Konstantin Niemeyer
Navin Kumar OjhaNavin Kumar Ojha
Navin Kumar Ojha
SPSebastian A. Porav
Sebastian A. Porav
DVDeivanayagabarathy Vinayagam
Deivanayagabarathy Vinayagam
OTOliver Thorn-Seshold
Oliver Thorn-Seshold
Directly probing the endogenous biological roles of target proteins with high spatial and temporal resolution, as non-invasively and reproducibly as possible, is a shared conceptual goal for research across many fields, as well as for targeted therapies. Here we describe the rational conceptual design and test-case practical implementation of a photopharmacological paradigm to empower high-performance photomodulation studies in vivo . TRPC4/5 ion channels are involved in many spatiotemporally resolved circuits, from pain and anxiety, to reproductive signaling, digestion, and obesity. To unpick their biology requires spatiotemporally precise tools, which were lacking. We developed “ideal efficacy photoswitch” ligands to control their diverse functions in situ . These E ⇆ Z- photoswitchable ligands bias TRPC[4]/5 channel activity with exquisite photocontrol, from strong agonism under 360 nm, to low agonism at 385 nm, to strong antagonism at 410-460 nm. Cryo-EM structures of both TRPC4 and TRPC5 with both Z- agonists and E- antagonists support the rationale for efficacy switching through competitive E/Z isomer binding. Crucially, since the E/Z ratio is exclusively determined by the light wavelength applied, their channel photocontrol is exclusively wavelength-dependent, yet drug-concentration-independent: so is reproducible from cell culture to >millimetre-depth tissues . Indeed, we were able to photocontrol both direct and downstream TRPC4/5 biology in cell lines or primary cells in culture, from calcium flux, to primary neuron excitability and adrenaline release; and even in tissues, photoswitching small intestine motility and peristalsis. The TRPC4/5 ligands we develop will thus unlock a range of high-precision investigations in TRP biology. More broadly, we propose that the success of this efficacy photoswitch program, from concept to tissue level translation, is mainly a consequence of how biology has evolved proteins for efficacy control. We therefore foresee that a variety of functionally responsive protein targets, not only sensory and signaling ion channels and receptors, will be amenable to similarly high-performance photocontrol even in vivo , if a new generation of reagent development adopts this paradigm of ideal efficacy photoswitching . Table of Contents Graphic:

1 July 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
DVDeivanayagabarathy Vinayagam
Deivanayagabarathy Vinayagam
DQDennis Quentin
Dennis Quentin
OSOleg Sitsel
Oleg Sitsel
FMFelipe Merino
Felipe Merino
MSMarkus Stabrin
Markus Stabrin
SRStefan Raunser
Stefan Raunser
Canonical transient receptor potential channels (TRPC) are involved in receptor-operated and/or store-operated Ca 2+ signaling. Inhibition of TRPCs by small molecules was shown to be promising in treating renal diseases. In cells, the channels are regulated by calmodulin. Molecular details of both calmodulin and drug binding have remained elusive so far. Here we report structures of TRPC4 in complex with a pyridazinone-based inhibitor and a pyridazinone-based activator and calmodulin. The structures reveal that both activator and inhibitor bind to the same cavity of the voltage-sensing-like domain and allow us to describe how structural changes from the ligand binding site can be transmitted to the central ion-conducting pore of TRPC4. Calmodulin binds to the rib helix of TRPC4, which results in the ordering of a previously disordered region, fixing the channel in its closed conformation. This represents a novel calmodulin-induced regulatory mechanism of canonical TRP channels.